今日盘中，华检医疗（01931.HK）股价大涨5.26%，引发市场关注。这一显著涨幅主要源于公司宣布的一项重大收购计划。
据公告，华检医疗拟通过其全资附属公司FinalTouchLtd.收购国富量子（00290.HK）约18.48亿股股份，占后者全部已发行股本的20.31%。收购总价约为31.42亿港元，将通过发行新股支付，发行价为每股9.69港元。此次收购完成后，华检医疗将成为国富量子的主要股东，并采用权益法将国富量子的财务业绩纳入其综合财务报表。
市场分析认为，此次收购是华检医疗推进RWA交易所战略的重要举措，有望带来显著的协同效应。通过此次战略布局，华检医疗将进一步完善其在RWA与数字金融领域的业务版图，并与国富量子在"链上金融"生态构建方面展开深度合作。这不仅有助于华检医疗拓展投资银行、证券经纪、资产管理等新业务，还将加速其在数字金融基础设施创新方面的发展。投资者对公司未来发展前景的看好，推动了股价的快速上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.